TradingAgents AISign inGet started
All stock profiles
ERASNASDAQHealthcare

ERASCA INC

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$14.35

-4.21%

Yahoo Finance · 10/30/2026

Industry: BiotechnologyCategory: Domestic Common StockCurrency: USDNews: 0 recent
Analyze ERAS free

One-year price history

Adjusted daily closes · 252 observations · as of Oct 30, 2026

Historical data, not a forecast

1 month

-1.6%

3 months

-19.6%

6 months

+43.1%

1 year

+483.3%

Year to date

+285.8%

52-week range

$2.20 – $22.47

Fundamental snapshot

Latest reported period: Jun 30, 2026

Sharadar reported data

Market cap

$5.02B

P/E

-17.5

P/B

13.9

P/S

—

Revenue

$0

Net income

-$287.22M

Diluted EPS

-0.95

Gross margin

—

Net margin

—

Return on equity

-80.40%

Total debt

$44.71M

Cash

$42.95M

Free cash flow

-$98.08M

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Jun 30, 2026$0-$44.08M——-$27.28M
Mar 31, 2026$0-$183.44M——-$27.42M
Dec 31, 2025$0-$29.09M——-$21.72M
Sep 30, 2025$0-$30.61M——-$21.66M
Jun 30, 2025$0-$33.88M——-$20.56M
Mar 31, 2025$0-$30.97M——-$31.64M
Dec 31, 2024$0-$32.23M——-$24.56M
Sep 30, 2024$0-$31.2M——-$22.42M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent ERAS news

All market news

No ticker-linked stories are in the current archive.